Home > Insider Trading > Filing (0000899243-20-032373)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1490978	Schrodinger Inc.	SDGR	Pharmaceutical Preparations (2834)	954284541

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1797727	Cony D'cruz	C/O Schrodinger, Inc., 120 West 45Th Street, 17Th Floor New York NY 10036	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-30	2,314	$4.34	2,314	No	4	M	Direct
Common Stock	Acquisiton	2020-11-30	2,061	$2.92	4,375	No	4	M	Direct
Common Stock	Disposition	2020-11-30	4,375	$70.30	0	No	4	S	Direct
Common Stock	Disposition	2020-11-30	2,000	$70.30	169,082	No	4	S	Indirect	By Cony and Pearl D'Cruz Revocable Trust dated August 20, 2019, and any amendments thereto

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	By Cony and Pearl D'Cruz Revocable Trust dated August 20, 2019, and any amendments thereto

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-11-30	2,314	$0.00	2,314	$4.34
Common Stock	Stock Option (right to buy)	Disposition	2020-11-30	2,061	$0.00	2,061	$2.92

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,065		2028-11-29	No	4	M	Direct
3,804		2027-06-01	No	4	M	Direct

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2020.
This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.
This option was granted on June 1, 2017. The shares underlying the option are scheduled to vest in equal yearly installments from January 1, 2017 through January 1, 2021.